Aspergillus: Rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999

Diagnostic Microbiology and Infectious Disease

Volumn 41, Issue 4, 2001, Pages 211-214

  Chandrasekar, P H ^a   Cutright, J L ^a   Manavathu, E K ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; CONFERENCE PAPER; CONTROLLED STUDY; DILUTION; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; INOCULATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; HUMANS; ITRACONAZOLE; PYRIMIDINES; TRIAZOLES;

EID: 0035685502     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(01)00295-4     Document Type: Conference Paper

References (17)

1. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole and amphotericin B
2. Fungal infections in cancer patients: An international autopsy survey
3. Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea pig model
4. Itraconazole resistance in Aspergillus fumigatus
5. Trends in the post-mortem epidemiology of invasive fungal infections at a university hospital
6. Clinical pharmacology of systemic antifungal agents: A comprehensive review of agents in use, current investigational compounds and putative targets for antifungal drug development
7. Clinical aspects of fungal infections in solid organ transplant recipients
8. In vitro testing of susceptibility to amphotericin B is a reliable clinical predictor of clinical outcome in invasive aspergillosis
9. A comparative study of the broth micro- and macro-dilution techniques for the determination of the in vitro susceptibility of Aspergillus fumigatus
10. Organism-dependent fungicidal activities of azoles
11. A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592)
12. Progress in the diagnosis and management of aspergillosis in bon marrow transplantation: 13 years' experience
13. The spectrum of non-Candida fungal infections following bone marrow transplantation
14. In vitro activity of SCH 56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp
15. Efficacy of SCH 56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus
16. A prospective study of infectious diseases following bone marrow transplantation: Emergence of Aspergillus and Cytomegalovirus as the major causes of mortality
17. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation